The involvement of Pharmacovigilance Centres in medication errors detection: A questionnaire-based analysis

International Journal of Risk and Safety in Medicine

Volumn 23, Issue 1, 2011, Pages 17-29

  Benabdallah, Ghita ^a,b   Benkirane, Raja ^a   Khattabi, Asmae ^a   Edwards, I Ralph ^b   Bencheikh, Rachida Soulaymani ^a  

^a Moroccan Pharmacovigilance Centre   (Morocco)

^b UPPSALA MONITORING CENTRE   (Sweden)

Author keywords

detecting; Involvement; medication errors; patient safety; Pharmacovigilance Centres

Indexed keywords

ANALGESIC AGENT; ANTACID AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIPYRETIC AGENT; ANTIRHEUMATIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CORTICOSTEROID; DIAZEPINE DERIVATIVE; HYPNOTIC AGENT; IMMUNOSUPPRESSIVE AGENT; INSULIN; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXAZEPINE DERIVATIVE; SEX HORMONE; THIAZEPINE DERIVATIVE; TOXOID; VACCINE;

ACUTE KIDNEY FAILURE; ANGIONEUROTIC EDEMA; ARTICLE; BLEEDING; COMA; CONVULSION; CORTICOSTEROID THERAPY; DIZZINESS; DRUG ERUPTION; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; E-MAIL; EPILEPSY; ERYTHRODERMA; EXPLORATORY RESEARCH; EXTRAPYRAMIDAL SYNDROME; FAX; GEOGRAPHIC DISTRIBUTION; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEMATEMESIS; HUMAN; HYPOTENSION; INFORMATION DISSEMINATION; INJECTION SITE REACTION; INTERNET; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MEDICATION ERROR; PARESTHESIA; PATIENT SAFETY; PERITONITIS; QUESTIONNAIRE; RETROSPECTIVE STUDY; SKIN TOXICITY; SOMNOLENCE; TELEPHONE; UNSPECIFIED SIDE EFFECT; VERTIGO; VOMITING; WORLD HEALTH ORGANIZATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; COMPUTER COMMUNICATION NETWORKS; DRUG AND NARCOTIC CONTROL; DRUG MONITORING; HUMANS; INTERNATIONAL COOPERATION; MANDATORY REPORTING; MEDICATION ERRORS; PATIENT PARTICIPATION; POISON CONTROL CENTERS; SELF REPORT; WORLD HEALTH ORGANIZATION;

EID: 79952684046     PISSN: 09246479     EISSN: 18786847     Source Type: Journal    
DOI: 10.3233/JRS-2011-0513     Document Type: Article

References (21)

1. L. Alj, M.D.W. Touzani, R. Benkirane, I.R. Edwards andR.Soulaymani, Detecting medication errors inpharmacovigilance database: Capacities and limits, Int J Risk Saf Med 19 (2007), 1-8.
2. D.M. Benjamin, Reducing medication errors and increasing patient safety: Case studies in clinical pharmacology, Journal of Clinical Pharmacology 43 (2003), 768-783. (Pubitemid 36759156)
3. R.R. Benkirane, R. Abouqal, C.C. Haimeur, et al., Incidence of adverse drugs events and medication errors in intensive care units: A prospective multicenter study, J Patient Saf 5 (2009), 16-22.
4. J. Braithwaite, M.T. Westbrook, N.A. Mallock, et al., Experiences of health professionals who conducted root cause analysis after undergoing a safety improvement programme, Qual saf health Care 15 (2006), 393-399. (Pubitemid 46025148)
5. D.C. Classen, S.L. Pestotnik, R.S. Evans, et al., Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality, JAMA 277 (1997), 301-306. (Pubitemid 27045010)
6. Discussion paper on adverse event and error reporting in healthcare, Available at: www.ismp.org/tools/whitepapers/concept.asp
7. I.W. Hammond, T.G. Gibbs, H.A. Seifert, et al., Database size and power to detect safety signals in pharmacovigilance, Expert Opin Drug Saf 6 (2007), 713-721. (Pubitemid 351308283)
8. B. Hugman and I.R. Edwards, The challenge of effectively communicating patient safety information, Expert Opin Drug Saf 4 (2006), 495-499. (Pubitemid 44468447)
9. ISMP medication error reporting programme, Available at: http://www.ismp.org/orderForms/reporterrortoISMP.asp
10. L.T. Khon, J.M. Corrigan and M.S. Donaldson, eds, To Err is Human. Building a Safer Health System, National Academy Press, Washington, DC, 1999.
11. J. Lazarou, B.H. Pomeranz and P.N. Corey, Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies, JAMA 279 (1998), 1200-1205. (Pubitemid 28193431)
12. The Erice Manifesto: For global reform of the safety of medicines in patient care, Drug Safety 30 (2007), 187-190.
13. The JointCommission2007NationalPatientSafetyGoals,Available at: http://books.google.es/books?id=mVRr9clAyW8C &pg=PA29&lpg=PA29&dq= Meeting+the+Joint+Commission's+2007+National+Patient+Safety+Goals+SBAR+techniq ue&source=bl&ots=ZYxRk7qD5S&sig=nZ626ClPw9WbCGbMBnl5XV0B9hg&hl= es&ei=J 38S6 yL4.
14. The Joint commission Guide to Improving Staff Communication, Joint Commission on Accreditation of Healthcare Organizations, Available at: http://books.google.es/books?id=LyEXGHd8AkIC&printsec=frontcover&dq= the+joint+commiss ion+guide+to+improving+staff+communication&source= bl&ots=DjdRp9ZrsB&sig=1 Feb8Jto4pX8QyLK7vZjSig VY &hl=es&ei= ufP8S.
15. E.J. Thomas, D.M. Studdert, H.R. Burstin, et al., Incidence and types of adverse events and negligent care in Utah and Colorado, Med Care 38 (2000), 261-271.
16. Twenty-ninth National Centres Annual Meeting of the WHO Drug Monitoring Programme, Lièges - Belgium, 9-11 October, 2006, Available at: www.who-umc.org/dynPage.aspx?id=30794.
17. Vigimed, Available at: http://www.who-umc.org/graphics/4473.pdf
18. G.N. Volans, L. Karalliedde and H.M. Wiseman, Poisons centres and the reporting of adverse drug events. The case for further development, Drug Safety 30 (2007), 191-194. (Pubitemid 46425632)
19. World Alliance for Patient Safety, Forward programme 2005, WHO, Available at: http://www.who.int/patientsafety/en/brochure final.pdf.
20. World Health Organization draft guidelines for Adverse Event reporting and Learning Systems, From information to action, Available at: http://www.who.int/patientsafety/events/05/Reporting Guidelines.pdf.
21. World Health Organization, The Importance of Pharmacovigilance, Safety Monitoring of Medicinal Products, WHO, Geneva, 2002.